Product Images Alvesco

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Alvesco NDC 59368-101 by Sixarp, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - image 01

Structural Formula - image 01

Figure 1 - image 02

Figure 1 - image 02

This is not readable.*

Figure 2 - image 03

Figure 2 - image 03

Figure 3 - image 04

Figure 3 - image 04

This is a description of the mean change in Forced Expiratory Volume in one second (FEV1) before the morning dose of medication over 12 weeks. The data compares the effect of Avesco 320 mcg/day and Avesco 640 mcg/day to a placebo. The results show a favorable impact on FEV1 for both dosages of Avesco compared to the placebo. The statistical significance of the difference is noted as p<0.05.*

Figure A - image 05

Figure A - image 05

Figure B - image 06

Figure B - image 06

Figure C - image 07

Figure C - image 07

Figure D - image 08

Figure D - image 08

Figure E - image 09

Figure E - image 09

Figure F - image 10

Figure F - image 10

Figure G - image 11

Figure G - image 11

Figure H - image 12

Figure H - image 12

Figure I - image 13

Figure I - image 13

Principal Display Panel - 80 mcg Carton - image 14

Principal Display Panel - 80 mcg Carton - image 14

This is a product description for ALVESCO® Inhalation Aerosol containing ciclesonide in propellant HFA-134a. Each 6.1g canister contains a solution of ciclesonide. The strength is 80 mcg/actuation. It is essential to follow the instructions provided in the package insert for proper administration. The canister should not be punctured or exposed to heat, open flame, or temperatures above 60°C. The product is manufactured by Covis Pharma and should be stored at 25°C (77°F) with excursions between 15-30°C permitted. The lot number and expiration date are indicated for product tracking.*

Principal Display Panel - 160 mcg Carton - image 15

Principal Display Panel - 160 mcg Carton - image 15

The text provides information on ALVESCO® Inhalation Aerosol containing ciclesonide in a propellant solution. It includes details on dosage, administration, storage instructions, and warnings. The strength of ALVESCO® is specified as 160 mcg/actuation and comes in a 6.1g canister with 60 metered actuations. The product is for oral inhalation use with the ALVESCO® Inhalation Aerosol actuator. The text also includes manufacturing details for Covis Pharma in Switzerland and mention of the United Kingdom.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.